Navigation Links
Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
Date:6/22/2010

DENVER, June 22 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).

"We are very pleased to announce these two very important accomplishments," said Douglass Simpson, President and CEO of Corgenix. "The newest patent expands our IP portfolio, and the acute coronary syndrome clinical trial reported remarkable results. Since cardiovascular disease is one of the world's leading causes of death, the early detection of atherosclerosis has become increasingly important, and we are optimistic about the ability of AtherOx to address this significant market."

The clinical trial was conducted at Saint Mary's Hospital in Waterbury, Conn., under the leadership of Thomas P. Greco, M.D.

European patent # EP 1 596 198 B, "Method of Measuring Oxidized LDL-Beta2-GP1-CRP Complex" was issued April 7, 2010. The patent is a method patent providing additional European protection to the components and assay procedure used to measure AtherOx complexes in biological samples. The latest patent adds to previous issued U.S. and European patents.

The clinical study, "Oxidized-LDL/B2-Glycoprotein I Complexes Are Associated With Disease Severity and Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndromes," was published in the American Journal of Clinical Pathology, 2010; 133:737-743.


'/>"/>
SOURCE Corgenix Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Corgenix to Exhibit AspirinWorks(R) Test at Pri-Med New York
2. Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents
3. Corgenix Secures $1,750,000 Asset Based Credit Facility Representing Initial Gross Proceeds of $1.109 Million
4. Corgenix Reports Third Quarter Fiscal 2009 Financial Results
5. Corgenix to Exhibit AspirinWorks(R) Test at ACC.09
6. Corgenix Reports Second Quarter Fiscal 2009 Financial Results
7. Corgenix to Host Conference Call to Discuss Second Quarter Results
8. Corgenix Signs Collaboration With Battelle
9. Corgenix Receives Two Additional Patents on AtherOx(R) Technology
10. Corgenix to Host Conference Call to Discuss First Quarter Results
11. Corgenix to Exhibit AspirinWorks(R) Test, Discuss New CHARISMA Trial Results at AHA 2008 Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 GraphDB™ 6.0 ... including improvements to the enterprise replication cluster, faster ... Lucene, SOLR and Elasticsearch. This release happens to ... performance triplestore – GraphDB™ was formerly known as ... the only mature enterprise resilient RDF triplestore will ...
(Date:8/19/2014)... Md. (PRWEB) August 19, 2014 ... liquid chromatography systems, Prominence-i and Nexera-i, adding to ... systems. Combining excellent functionality, an intuitive operating environment, ... and a more efficient workflow for conventional to ... feature innovative, intuitive and intelligent design so users ...
(Date:8/19/2014)... Aug. 19, 2014 A Geisinger researcher on ... for a Centers for Disease Control and Prevention (CDC) ... public health concern. Joseph Boscarino , ... of a team of researchers nominated for the Centers ... Science Award for Data Methods and Study Design. ...
(Date:8/19/2014)... Research and Markets  has announced the addition of the ... report to their offering. This report ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Asia-Pacific , and Rest of ... 2012 through 2020. Market data and analytics are derived from ...
Breaking Biology Technology:Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 3Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 4Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3Geisinger investigator nominated for federal award 2Geisinger investigator nominated for federal award 3Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2
... ... to cap the well that is leaking vast quantities of oil into ... cleaning up the oil that is slowly creeping ashore and affecting sensitive ... end, however, significant obstacles prevent current methods of bioremediation from being effective. ...
... June 3 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a ... autoimmune disorders, today announced Colin Hislop , M.D. has been promoted ... James E. Pennington , M.D., who will continue to serve as ... , ...
... June 3 Alexandria Real Estate Equities, Inc. (NYSE: ... Science Industry®, today announced that the Cambridge Planning Board has ... known as the Binney Street Project.  This development, with its ... East Cambridge, is positioned to be the epicenter of Cambridge,s ...
Cached Biology Technology:Evolugate Launches Bioremediation Project To Mitigate The Gulf Oil Spill 2Evolugate Launches Bioremediation Project To Mitigate The Gulf Oil Spill 3Anthera Pharmaceuticals Promotes Colin Hislop, M.D., to Chief Medical Officer 2Anthera Pharmaceuticals Promotes Colin Hislop, M.D., to Chief Medical Officer 3Anthera Pharmaceuticals Promotes Colin Hislop, M.D., to Chief Medical Officer 4Alexandria Real Estate Equities, Inc. Receives Final Approval From City of Cambridge to Develop Its East Cambridge State-of-the-Art Life Science Community 2Alexandria Real Estate Equities, Inc. Receives Final Approval From City of Cambridge to Develop Its East Cambridge State-of-the-Art Life Science Community 3
(Date:8/20/2014)... into a chili pepper causes a burning spiciness that ... exploring the chili pepper,s effect are using their findings ... of pain, which can be caused by inflammation or ... which is being tested in clinical trials, in ACS, ... and colleagues explain that decades ago, scientists had pegged ...
(Date:8/20/2014)... who are poor experience higher cortisol levels in pregnancy ... the stress hormone, putting them at greater risk ... new research from the University of Colorado Denver. , ... Journal of Human Biology , is the first to ... the socioeconomic status of their mothers during pregnancy. , ...
(Date:8/20/2014)... State University researchers have developed methods for electronically manipulating ... electrical signals moths use to control those muscles. The ... moths, or "biobots," for use in emergency response. , ... we can control the movement of moths for use ... Dr. Alper Bozkurt, an assistant professor of electrical and ...
Breaking Biology News(10 mins):CU Denver researcher shows economic disparities impact infant health 2Research paves way for development of cyborg moth 'biobots' 2
... Autologous (self-donated) mononuclear cells derived from bone marrow (BMMNCs) ... transplanted into patients with diabetes who are suffering from ... a complication of diabetes. The team of researchers in ... results in a recent issue of Cell Transplantation ...
... Jellyfish are increasing in the majority of the world,s ... jellyfish abundance by University of British Columbia researchers. ... the journal Hydrobiologia , UBC scientists examined data ... world,s 66 Large Marine Ecosystems. They found increasing jellyfish ...
... to punish others who lie, cheat, steal or violate other ... to benefit personally, is a distinctly human behavior. There is ... this "I punish you because you harmed him" fashion. Although ... institutionalized in human legal systems and economists have identified it ...
Cached Biology News:Autologous bone marrow-derived mononuclear cell transplants can reduce diabetic amputations 2Jellyfish on the rise: UBC study 2Crime and punishment: The neurobiological roots of modern justice 2Crime and punishment: The neurobiological roots of modern justice 3Crime and punishment: The neurobiological roots of modern justice 4Crime and punishment: The neurobiological roots of modern justice 5
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
ID clarifier: With ethidium bromide (50 μg/ml)...
... Pre-tested for optimal colony ... the growth of anchorage-dependent ... methylcellulose colony-forming assays of ... cells. Not suitable for ...
... simultaneous dual parameter assay for mitochondrial ... activity. Active caspases are detected by ... which are cell-permeable, non-cytotoxic and bind ... the cells. At the same time ...
Biology Products: